Wolverine Stack
Informal combination of BPC-157 and TB-500 promoted for injury recovery. Published evidence concerns the components separately and is dominated by preclinical work; no controlled study has established the safety, efficacy, composition, or pharmacokinetics of the combination.
Pharmacokinetic model
A route-level PK model for wolverine stack is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Peptide Combination
- Suggested cadence
- once daily
Research behind this entry
-
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing
Review of BPC-157 soft-tissue research found that the evidence was overwhelmingly from small rodent models and had not established efficacy in humans. It evaluates one proposed component, not the Wolverine Stack…
-
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
Narrative review found that BPC-157 and TB-500 claims remain primarily preclinical, with inadequate human orthopaedic evidence and unknown indications, dosing, frequency, and duration. It provides no trial of the…
-
Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain.
This citation reports a human primary study involving analogue or class evidence, not direct identity-level evidence for Wolverine Stack. The study investigated BPC-157 alone, not the marketed BPC-157/TB-500…
3 published studies referenced in the app, each with a plain-language summary.